{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T13:20:17Z","timestamp":1774272017133,"version":"3.50.1"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T00:00:00Z","timestamp":1761609600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Translational Autoimmunity"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.jtauto.2025.100328","type":"journal-article","created":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T01:02:21Z","timestamp":1761786141000},"page":"100328","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["The clinical characteristics and treatment response of myasthenia gravis with positive thyroid peroxidase antibody or thyroid globulin antibody"],"prefix":"10.1016","volume":"11","author":[{"given":"Hanyu","family":"Xin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-4150-1612","authenticated-orcid":false,"given":"Mingou","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtauto.2025.100328_bib1","author":"Khani-Habibabadi"},{"key":"10.1016\/j.jtauto.2025.100328_bib2","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41572-019-0079-y","article-title":"Myasthenia gravis","volume":"5","author":"Gilhus","year":"2019","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.jtauto.2025.100328_bib3","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1007\/s00415-015-7963-5","article-title":"Myasthenia gravis: a clinical-immunological update","volume":"263","author":"Binks","year":"2016","journal-title":"J. Neurol."},{"key":"10.1016\/j.jtauto.2025.100328_bib4","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1212\/WNL.0b013e3181a41211","article-title":"Incidence and mortality rates of myasthenia gravis and myasthenic crisis in US hospitals","volume":"72","author":"Alshekhlee","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.jtauto.2025.100328_bib5","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/0022-510X(91)90260-E","article-title":"Prognosis of myasthenia gravis: a multicenter follow-up study of 844 patients","volume":"106","author":"Beghi","year":"1991","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jtauto.2025.100328_bib6","article-title":"Incidence, mortality, and economic burden of myasthenia gravis in China: a nationwide population-based study","volume":"5","author":"Chen","year":"2020","journal-title":"Lancet Reg Health West Pac"},{"key":"10.1016\/j.jtauto.2025.100328_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2019.102368","article-title":"Thyroid disorders in patients with myasthenia gravis: a systematic review and meta-analysis","volume":"18","author":"Song","year":"2019","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jtauto.2025.100328_bib8","doi-asserted-by":"crossref","first-page":"362","DOI":"10.3109\/08916934.2015.1030614","article-title":"Complicating autoimmune diseases in myasthenia gravis: a review","volume":"48","author":"Nacu","year":"2015","journal-title":"Autoimmunity"},{"key":"10.1016\/j.jtauto.2025.100328_bib9","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1159\/000510701","article-title":"Disappearance of anti-thyroid autoantibodies following thymectomy in patients with myasthenia gravis","volume":"10","author":"Rotondo Dottore","year":"2021","journal-title":"Eur. Thyroid J."},{"key":"10.1016\/j.jtauto.2025.100328_bib10","article-title":"Myasthenia gravis and its association with thyroid diseases","volume":"12","author":"Amin","year":"2020","journal-title":"Cureus"},{"key":"10.1016\/j.jtauto.2025.100328_bib11","doi-asserted-by":"crossref","first-page":"NP49","DOI":"10.1177\/11206721221077800","article-title":"Post-COVID simultaneous onset of graves' disease and ocular myasthenia gravis in a patient with a complex ocular motility impairment","volume":"33","author":"De Giglio","year":"2023","journal-title":"Eur. J. Ophthalmol."},{"key":"10.1016\/j.jtauto.2025.100328_bib12","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1002\/mus.27167","article-title":"Immune profiling beyond antibodies in double seronegative and acetylcholine receptor antibody positive myasthenia gravis: what do we learn?","volume":"63","author":"Kushlaf","year":"2021","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jtauto.2025.100328_bib13","series-title":"Correlation Between Myasthenia Gravis and Thyroid Dysfunction [D]","author":"Ji","year":"2008"},{"key":"10.1016\/j.jtauto.2025.100328_bib14","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.autrev.2014.01.007","article-title":"Hashimoto thyroiditis: clinical and diagnostic criteria","volume":"13","author":"Caturegli","year":"2014","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jtauto.2025.100328_bib15","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/jhg.2016.135","article-title":"Gender-dependent and age-of-onset-specific association of the rs11675434 single-nucleotide polymorphism near TPO with susceptibility to graves' ophthalmopathy","volume":"62","author":"Ku\u015b","year":"2017","journal-title":"J. Hum. Genet."},{"key":"10.1016\/j.jtauto.2025.100328_bib16","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s12519-014-0476-y","article-title":"Thyroid peroxidase antibody positivity and triiodothyronine levels are associated with pediatric graves' ophthalmopathy","volume":"10","author":"Lee","year":"2014","journal-title":"World J Pediatr"},{"key":"10.1016\/j.jtauto.2025.100328_bib17","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/8129497","article-title":"Predictive factors of development of Graves' Ophthalmopathy for Patients with Juvenile Graves' disease","volume":"2016","author":"Jarusaitiene","year":"2016","journal-title":"Int J Endocrinol"},{"key":"10.1016\/j.jtauto.2025.100328_bib18","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1212\/WNL.46.1.30","article-title":"Muscles of a different 'color': the unusual properties of the extraocular muscles may predispose or protect them in neurogenic and myogenic disease","volume":"46","author":"Porter","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.jtauto.2025.100328_bib19","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/mus.20950","article-title":"Lifetime course of myasthenia gravis","volume":"37","author":"Grob","year":"2008","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jtauto.2025.100328_bib20","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0079-6123(05)51002-1","article-title":"Biological organization of the extraocular muscles","volume":"151","author":"Spencer","year":"2006","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.jtauto.2025.100328_bib21","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s12974-024-03095-7","article-title":"Thymic gene expression analysis reveals a potential link between HIF-1A and Th17\/Treg imbalance in thymoma associated myasthenia gravis","volume":"21","author":"Alt\u0131n\u00f6nder","year":"2024","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.jtauto.2025.100328_bib22","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/ni1254","article-title":"Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages","volume":"6","author":"Harrington","year":"2005","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jtauto.2025.100328_bib23","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1600-0404.2006.00608.x","article-title":"Titin and ryanodine receptor antibodies in myasthenia gravis","volume":"183","author":"Skeie","year":"2006","journal-title":"Acta Neurol. Scand. Suppl."},{"key":"10.1016\/j.jtauto.2025.100328_bib24","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0198-8859(02)00360-9","article-title":"HLA-DR and HLA-DQ polymorphism in human thyroglobulin-induced autoimmune thyroiditis: DR3 and DQ8 transgenic mice are susceptible","volume":"63","author":"Wan","year":"2002","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.jtauto.2025.100328_bib25","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1212\/01.wnl.0000339103.08830.86","article-title":"HLA class II allele analysis in MuSK-positive myasthenia gravis suggests a role for DQ5","volume":"72","author":"Bartoccioni","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.jtauto.2025.100328_bib26","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1038\/nri3084","article-title":"Towards a systems understanding of MHC class I and MHC class II antigen presentation","volume":"11","author":"Neefjes","year":"2011","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jtauto.2025.100328_bib27","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1172\/JCI60047","article-title":"Mechanisms of thyroid hormone action","volume":"122","author":"Brent","year":"2012","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.jtauto.2025.100328_bib28","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1136\/bmj.287.6394.705","article-title":"Endocrine myopathies","volume":"287","author":"Kendall-Taylor","year":"1983","journal-title":"Br. Med. J. (Clin. Res. Ed.)"},{"key":"10.1016\/j.jtauto.2025.100328_bib29","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1210\/jc.2009-1719","article-title":"Increased circulating pro-inflammatory cytokines and Th17 lymphocytes in Hashimoto's thyroiditis","volume":"95","author":"Figueroa-Vega","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jtauto.2025.100328_bib30","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/mus.22070","article-title":"Increased serum interleukin-17 levels in patients with myasthenia gravis","volume":"44","author":"Roche","year":"2011","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jtauto.2025.100328_bib31","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nature04753","article-title":"Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells","volume":"441","author":"Bettelli","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.jtauto.2025.100328_bib32","article-title":"Thymoma and myasthenia gravis: an examination of a paraneoplastic manifestation","volume":"15","author":"Itani","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.jtauto.2025.100328_bib33","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1080\/08916930310001603046","article-title":"Cytokines in thyroid autoimmunity","volume":"36","author":"Ajjan","year":"2003","journal-title":"Autoimmunity"}],"container-title":["Journal of Translational Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589909025000632?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589909025000632?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T09:24:26Z","timestamp":1765358666000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589909025000632"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":33,"alternative-id":["S2589909025000632"],"URL":"https:\/\/doi.org\/10.1016\/j.jtauto.2025.100328","relation":{},"ISSN":["2589-9090"],"issn-type":[{"value":"2589-9090","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The clinical characteristics and treatment response of myasthenia gravis with positive thyroid peroxidase antibody or thyroid globulin antibody","name":"articletitle","label":"Article Title"},{"value":"Journal of Translational Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtauto.2025.100328","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100328"}}